Healthcare Equipment and Supplies
Company Overview of ReVision Optics, Inc.
ReVision Optics, Inc. develops optical solutions for the treatment of presbyopia. It offers Raindrop Near Vision Corneal Inlay, a refractive surgery solution for near vision lost by the eye’s natural aging process. The company markets in products in the United States, Europe, Canada, Australia, and Japan. The company was formerly known as IntraLens Vision, Inc. and changed its name to ReVision Optics, Inc. in October 2005. ReVision Optics, Inc. was founded in 1996 and is based in Lake Forest, California.
25651 Atlantic Ocean Drive
Lake Forest, CA 92630-8835
Founded in 1996
Key Executives for ReVision Optics, Inc.
Chief Executive Officer, President and Director
Vice President of Operations
Chief Compliance Officer and Vice President of Regulatory Affairs & Quality Assurance
Compensation as of Fiscal Year 2016.
ReVision Optics, Inc. Key Developments
ReVision Optics Secures $10 Million Credit Facility from Square 1 Bank
Aug 18 16
ReVision Optics, Inc. announced that it has secured a $10 million credit facility from Square 1 Bank, a division of Pacific Western Bank. RVO announced receipt of U.S. Food and Drug Administration (FDA) approval for its Raindrop® Near Vision Inlay for the surgical correction of presbyopia on June 29, 2016. Proceeds from the credit facility will be used for working capital purposes including commercial operations.
ReVision Optics, Inc. Announces Receipt of U.S. Food and Drug Administration (FDA) Approval for its Raindrop® Near Vision Inlay for the Surgical Correction of Presbyopia
Aug 18 16
ReVision Optics, Inc. announced receipt of U.S. Food and Drug Administration (FDA) approval for its Raindrop® Near Vision Inlay for the surgical correction of presbyopia on June 29, 2016. The Raindrop Near Vision Inlay is comprised of approximately 80% water and has a refractive index very similar to the cornea. It is placed in the cornea of the non-dominant eye during a 10-minute procedure and is transparent, therefore does not restrict the amount of light reaching the retina. The reshaping of the anterior curvature of the cornea improves near vision. The Raindrop Near Vision Inlay has received approval by the U.S. Food and Drug Administration, authorization to affix the CE Mark for the European Union, license approval by the Ministry of Food and Drug Safety (South Korea), approval by the Therapeutic Goods Administration (Australia), and registration with the Medicines and Medical Safety Authority (New Zealand). Other country-specific registrations are pending.
ReVision Optics Names Dr. Nick J. Manesis as Vice President of R&D
Aug 10 16
ReVision Optics, Inc. announced the appointment of Nick J. Manesis, PhD as Vice President of R&D. Dr. Manesis brings to RVO nearly 30 years of materials research and development experience, including at the leading ophthalmic companies Allergan and CooperVision. Dr. Manesis most recently was Vice President at a specialty materials company Solaris Technology Group, where he was engaged in building out a technology platform for life science applications.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|